Ziftomenib combinations show promising frontline AML results, expanding trials with chemo and targeted partners; phase 3 aims ...
The panel classifies pediatric AML into 3 primary categories based on the World Health Organization criteria: AML with defining genetic abnormalities, AML defined by differentiation, and myeloid ...
"EHA26: AvenCell’s AVC-201-01 switchable allogeneic CAR T offers early validation in AML" was originally created and ...
The European Union (E.U) zone is set for tougher crypto regulation in 2027 as a new anti-money laundering (AML) policy goes ...
Bhavana “Tina” Bhatnagar, DO, reflects on AML’s transformation from few treatment options to targeted therapies and efforts to increase access to them. Acute myeloid leukemia (AML) has historically ...
Venetoclax plus pediatric-inspired chemotherapy yielded an 87% post-induction response in adult T-ALL, with 75% MRD negativity among complete remissions and strong activity in ETP-ALL. Cytopenias were ...
The BSA-AML Compliance Group is thrilled to announce the return of the Annual BSA/AML Gaming Conference, the most respected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results